Retraction Note: effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women

被引:0
|
作者
Erastus K Ngemu
Christopher Khayeka–Wandabwa
Eliningaya J Kweka
Joseph K Choge
Edward Anino
Elijah Oyoo-Okoth
机构
[1] University of Eldoret,School of Science, Department of Biochemistry
[2] Jomo Kenyatta University of Agriculture and Technology (JKUAT),Institute of Tropical Medicine and Infectious Diseases (ITROMID)
[3] Division of Livestock and Human Diseases Vector Control,Tropical Pesticides Research Institute
[4] Mosquito Section,School of Health Sciences
[5] University of Eastern Africa,School Natural Resources and Environmental Studies
[6] Karatina University,undefined
关键词
D O I
10.1186/1756-0500-7-868
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
    Ngemu E.K.
    Khayeka-Wandabwa C.
    Kweka E.J.
    Choge J.K.
    Anino E.
    Oyoo-Okoth E.
    [J]. BMC Research Notes, 7 (1)
  • [2] Getting pregnant women on to HAART (highly active antiretroviral therapy); developing a strategy for advanced prevention of mother-to-child transmission of HIV (PMTCT plus ) in rural Tanzania
    Edmonds, S.
    Shangalawe, L.
    Meadway, J.
    [J]. HIV MEDICINE, 2009, 10 : 26 - 26
  • [3] The value of highly active antiretroviral therapy in the prevention of mother-to-child transmission of HIV
    Chama, C.
    Gashau, W.
    Oguche, S.
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2007, 27 (02) : 134 - 137
  • [4] Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy
    Medrano, Jose
    Soriano, Vicente
    [J]. MEDICINA CLINICA, 2009, 132 (13): : 505 - 506
  • [5] Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy
    Giaquinto, C
    Ruga, E
    De Rossi, A
    Grosch-Wörner, I
    Mok, J
    de José, I
    Bates, I
    Hawkins, F
    de Guevara, CL
    Peña, JM
    Garcia, JG
    Lopez, JRA
    Garcia-Rodriguez, MC
    Asensi-Botet, F
    Otero, MC
    Pérez-Tamarit, DP
    Suarez, G
    Scherpbier, H
    Kreyenbroek, M
    Boer, K
    Bohlin, AB
    Lindgren, S
    Ehrnst, A
    Belfrage, E
    Navér, L
    Lidman, K
    Anzen, B
    Levy, J
    Barlow, P
    Hainaut, M
    Peltier, A
    Goetghebuer, T
    Ferrazin, A
    Bassetti, D
    De Maria, A
    Gotta, C
    Mûr, A
    Payà, A
    Viñolas, M
    López-Vilchez, MA
    Rovira
    Carreras, R
    Valerius, NH
    Jimenez, J
    Coll, O
    Suy, A
    Perez, JM
    Fortuny, C
    Caro, MC
    Canet, Y
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 40 (03) : 458 - 465
  • [6] Measuring retention in care for HIV-positive pregnant women in Prevention of Mother-to-Child Transmission of HIV (PMTCT) option B+ programs: the Mozambique experience
    Laurence Ahoua
    Shino Arikawa
    Thierry Tiendrebeogo
    Maria Lahuerta
    Dario Aly
    Renaud Becquet
    Francois Dabis
    [J]. BMC Public Health, 20
  • [7] Measuring retention in care for HIV-positive pregnant women in Prevention of Mother-to-Child Transmission of HIV (PMTCT) option B plus programs: the Mozambique experience
    Ahoua, Laurence
    Arikawa, Shino
    Tiendrebeogo, Thierry
    Lahuerta, Maria
    Aly, Dario
    Becquet, Renaud
    Dabis, Francois
    [J]. BMC PUBLIC HEALTH, 2020, 20 (01)
  • [8] Potential impact of drugs of abuse on mother-to-child transmission (MTCT) of HIV in the era of highly active antiretroviral therapy (HAART)
    Purohit, Vishnudutt
    Rapaka, Rao S.
    Schnur, Paul
    Shurtleff, David
    [J]. LIFE SCIENCES, 2011, 88 (21-22) : 909 - 916
  • [9] Mother-to-Child Transmission (MTCT) of HIV and Drugs of Abuse in Post-Highly Active Antiretroviral Therapy (HAART) Era
    Purohit, Vishnudutt
    Rapaka, Rao S.
    Shurtleff, David
    [J]. JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2010, 5 (04) : 507 - 515
  • [10] Mother-to-Child Transmission (MTCT) of HIV and Drugs of Abuse in Post-Highly Active Antiretroviral Therapy (HAART) Era
    Vishnudutt Purohit
    Rao S. Rapaka
    David Shurtleff
    [J]. Journal of Neuroimmune Pharmacology, 2010, 5 : 507 - 515